Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

Determination of the presence of epidermal growth factor receptor (EGFR) gene mutation is useful for predicting the efficacy of gefitinib. However, the survival rate following the initiation of treatment with gefitinib varies among individuals. A retrospective study was conducted to investigate the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: INOMATA, MINEHIKO, HAYASHI, RYUJI, YAMAMOTO, AZUSA, TOKUI, KOTARO, TAKA, CHIHIRO, OKAZAWA, SEISUKE, KAMBARA, KENTA, SUZUKI, KENSUKE, ICHIKAWA, TOMOMI, YAMADA, TORU, MIWA, TOSHIRO, KASHII, TATSUHIKO, MATSUI, SHOKO, TOBE, KAZUYUKI, IMURA, JOHJI
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486842/
https://ncbi.nlm.nih.gov/pubmed/26171184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.568
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars